CDEK
← All organizations

Lonza

For profitWebsite ↗

Also known as: Applied Science & Performance Institute | Lonza Inc. | Lonza Ltd. | Lonza Walkersville, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Dec 1, 2014

First marketed drug

Jul 11, 2017

Last known activity

Mar 24, 2025

Timeline

1890s

  1. Jun 1, 1897

    Lonza— Founded

2000s

  1. May 27, 2008

    Amaxa Biosystems— Acquired

  2. Nov 3, 2009

    Algonomics— Acquired

2010s

  1. May 20, 2010

    Moda Technology Partners— Acquired

  2. Jun 30, 2016

    Triangle Research Labs— Acquired

  3. Aug 15, 2016

    InterHealth Nutraceuticals— Acquired

  4. Dec 12, 2016

    Capsugel— Acquired

  5. May 16, 2017

    HansaBioMed— Acquired

  6. May 30, 2017

    PharmaCell— Acquired

  7. Jul 11, 2017

    epinephrine— Marketing Organization

  8. Aug 4, 2017

    Micromacinazione— Acquired

Drugs by trial phase (17 distinct, 28 trials)

Phase 2 (1 own, 2 via acquisition)

Marketed drugs (2)

Subsidiaries (9 direct, 12 total across the full acquisition tree)

Recent trials (13)

Details

Founded
Basel, CH Jun 1, 1897
Last known activity
Mar 24, 2025